Skip to main content

Table 1 Association between NB patients’ clinicopathological factors and miR-149 expression

From: miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma

Clinicopathologic featuresN (%)Relative miR-149 levelP value
High (%)Low (%)
Total cases42 (100.0)15 (35.7)27 (64.3) 
Age (years)   0.3526
 ≥ 2.524 (57.1)10 (41.7)14 (58.3) 
 < 2.518 (42.9)5 (27.8)13 (72.2) 
Gender   0.3939
 Male26 (61.9)8 (30.8)18 (69.2) 
 Female16 (38.1)7 (43.8)9 (56.2) 
INSS stage   0.0376
 I–II19 (45.2)10 (52.6)9 (47.4) 
 III–IV23 (54.8)5 (21.7)18 (78.3) 
Lymph node metastasis   0.0241
 No27 (64.3)13 (48.1)14 (51.9) 
 Yes15 (35.7)2 (13.3)13 (86.7) 
  1. NB neuroblastoma, INSS International Neuroblastoma Staging System